BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo L, Zhou Y, Chen Y, Sun H, Wang Y, Qu Y. LncRNA ASAP1-IT1 positively modulates the development of cholangiocarcinoma via hedgehog signaling pathway. Biomed Pharmacother 2018;103:167-73. [PMID: 29653361 DOI: 10.1016/j.biopha.2018.04.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Sharma U, Tuli HS, Uttam V, Choudhary R, Sharma B, Sharma U, Prakash H, Jain A. Role of Hedgehog and Hippo signaling pathways in cancer: A special focus on non-coding RNAs. Pharmacological Research 2022;186:106523. [DOI: 10.1016/j.phrs.2022.106523] [Reference Citation Analysis]
2 Sonawala K, Ramalingam S, Sellamuthu I. Influence of Long Non-Coding RNA in the Regulation of Cancer Stem Cell Signaling Pathways. Cells 2022;11:3492. [DOI: 10.3390/cells11213492] [Reference Citation Analysis]
3 Ghafouri-fard S, Safarzadeh A, Hussen BM, Taheri M, Samsami M. A review on the role of ncRNAs in the pathogenesis of cholangiocarcinoma. International Journal of Biological Macromolecules 2022. [DOI: 10.1016/j.ijbiomac.2022.11.144] [Reference Citation Analysis]
4 Hajiesmailpoor Z, Tabnak P, Ahmadzadeh B, Ebrahimi SS, Faal B, Mashatan N. Role of hedgehog signaling related non-coding RNAs in developmental and pathological conditions. Biomedicine & Pharmacotherapy 2022;153:113507. [DOI: 10.1016/j.biopha.2022.113507] [Reference Citation Analysis]
5 Han X, Li B. The emerging role of noncoding RNAs in the Hedgehog signaling pathway in cancer. Biomed Pharmacother 2022;154:113581. [PMID: 36037783 DOI: 10.1016/j.biopha.2022.113581] [Reference Citation Analysis]
6 Sargazi ML, Jafarinejad-Farsangi S, Moazzam-Jazi M, Rostamzadeh F, Karam ZM. The crosstalk between long non-coding RNAs and the hedgehog signaling pathway in cancer. Med Oncol 2022;39:127. [PMID: 35716241 DOI: 10.1007/s12032-022-01710-2] [Reference Citation Analysis]
7 Dandapath I, Gupta R, Singh J, Shukla N, Jha P, Sharma V, Suri A, Sharma MC, Suri V, Sarkar C, Kulshreshtha R. Long Non-coding RNA and mRNA Co-expression Network Reveals Novel Players in Pleomorphic Xanthoastrocytoma. Mol Neurobiol 2022. [PMID: 35674862 DOI: 10.1007/s12035-022-02893-5] [Reference Citation Analysis]
8 Liu Y, Hu C, Qu X, Chen H, Liu L, Zhou L, Liu S, Li G, Zhou Y. Novel Role of Long Non-Coding RNA ASAP1-IT1 in Progression of Hepatocellular Carcinoma. Front Oncol 2022;12:746896. [DOI: 10.3389/fonc.2022.746896] [Reference Citation Analysis]
9 Wu Y, Hayat K, Hu Y, Yang J. Long Non-Coding RNAs as Molecular Biomarkers in Cholangiocarcinoma. Front Cell Dev Biol 2022;10:890605. [DOI: 10.3389/fcell.2022.890605] [Reference Citation Analysis]
10 Ma X, Su J, Wang B, Jin X, Khalaf OI. Identification of Characteristic Genes in Whole Blood of Intervertebral Disc Degeneration Patients by Weighted Gene Coexpression Network Analysis (WGCNA). Computational and Mathematical Methods in Medicine 2022;2022:1-17. [DOI: 10.1155/2022/6609901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Liu Y, Yang Y, Zhang L, Lin J, Li B, Yang M, Li H, Chen K, Zhao W. LncRNA ASAP1-IT1 enhances cancer cell stemness via regulating miR-509-3p/YAP1 axis in NSCLC. Cancer Cell Int 2021;21:572. [PMID: 34715859 DOI: 10.1186/s12935-021-02270-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Zhao S, Zhang X, Chen S, Zhang S. Long noncoding RNAs: fine-tuners hidden in the cancer signaling network. Cell Death Discov 2021;7:283. [PMID: 34635646 DOI: 10.1038/s41420-021-00678-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Anichini G, Carrassa L, Stecca B, Marra F, Raggi C. The Role of the Hedgehog Pathway in Cholangiocarcinoma. Cancers (Basel) 2021;13:4774. [PMID: 34638259 DOI: 10.3390/cancers13194774] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Safarpour AR, Askari H, Ejtehadi F, Azarnezhad A, Raeis-Abdollahi E, Tajbakhsh A, Abazari MF, Tarkesh F, Shamsaeefar A, Niknam R, Sivandzadeh GR, Lankarani KB, Ejtehadi F. Cholangiocarcinoma and liver transplantation: What we know so far? World J Gastrointest Pathophysiol 2021; 12(5): 84-105 [PMID: 34676129 DOI: 10.4291/wjgp.v12.i5.84] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Swaminathan G, Shigna A, Kumar A, Byroju VV, Durgempudi VR, Dinesh Kumar L. RNA Interference and Nanotechnology: A Promising Alliance for Next Generation Cancer Therapeutics. Front Nanotechnol 2021;3:694838. [DOI: 10.3389/fnano.2021.694838] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
16 Sun HB, Zhang GC, Liu J, Nie CS. Long noncoding RNA LINC00184 facilitates the proliferation, metastasis, and adenine metabolism of cholangiocarcinoma via modulating hsa-miR-23b-3p/ANXA2 axis. Environ Toxicol 2021;36:1576-90. [PMID: 33913242 DOI: 10.1002/tox.23154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Merdrignac A, Papoutsoglou P, Coulouarn C. Long Noncoding RNAs in Cholangiocarcinoma. Hepatology 2021;73:1213-26. [PMID: 32865244 DOI: 10.1002/hep.31534] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
18 Wang K, Hu YB, Zhao Y, Ye C. Long non‑coding RNA ASAP1‑IT1 suppresses ovarian cancer progression by regulating Hippo/YAP signaling. Int J Mol Med 2021;47:44. [PMID: 33576454 DOI: 10.3892/ijmm.2021.4877] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
19 Liu X, Yin Z, Xu L, Liu H, Jiang L, Liu S, Sun X. Upregulation of LINC01426 promotes the progression and stemness in lung adenocarcinoma by enhancing the level of SHH protein to activate the hedgehog pathway. Cell Death Dis 2021;12:173. [PMID: 33568633 DOI: 10.1038/s41419-021-03435-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
20 Yang Y, Deng X, Li Q, Wang F, Miao L, Jiang Q. Emerging roles of long noncoding RNAs in cholangiocarcinoma: Advances and challenges. Cancer Commun (Lond) 2020;40:655-80. [PMID: 33142045 DOI: 10.1002/cac2.12109] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
21 Sun M, Liu X, Xia L, Chen Y, Kuang L, Gu X, Li T. A nine-lncRNA signature predicts distant relapse-free survival of HER2-negative breast cancer patients receiving taxane and anthracycline-based neoadjuvant chemotherapy. Biochem Pharmacol 2021;189:114285. [PMID: 33069665 DOI: 10.1016/j.bcp.2020.114285] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
22 Kang Z, Guo L, Zhu Z, Qu R. Identification of prognostic factors for intrahepatic cholangiocarcinoma using long non-coding RNAs-associated ceRNA network. Cancer Cell Int 2020;20:315. [PMID: 32694937 DOI: 10.1186/s12935-020-01388-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
23 Le Q, Yu Z. Two new α, β-unsaturated bis-enone derivatives: Anti-gastric cancer activity and docking study. MGC 2020;19:1-7. [DOI: 10.3233/mgc-190810] [Reference Citation Analysis]
24 Liu Z, Yang H, Hou R, Li E, Liu X. Synthesis, crystal structure, anti-colon cancer activity of a new heterocycles compound. MGC 2019;18:421-6. [DOI: 10.3233/mgc-190785] [Reference Citation Analysis]
25 Bao W, Cao F, Ni S, Yang J, Li H, Su Z, Zhao B. lncRNA FLVCR1-AS1 regulates cell proliferation, migration and invasion by sponging miR-485-5p in human cholangiocarcinoma. Oncol Lett 2019;18:2240-7. [PMID: 31404302 DOI: 10.3892/ol.2019.10577] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
26 Jiang F, Ling X. The Advancement of Long Non-Coding RNAs in Cholangiocarcinoma Development. J Cancer. 2019;10:2407-2414. [PMID: 31258745 DOI: 10.7150/jca.32411] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
27 Qiu G, Ma D, Li F, Sun D, Zeng Z. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma. Int J Oncol 2019;55:45-58. [PMID: 31059014 DOI: 10.3892/ijo.2019.4798] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
28 Li J, Huang L, Li Z, Zhong X, Tai S, Jiang X, Cui Y. Functions and roles of long noncoding RNA in cholangiocarcinoma. J Cell Physiol. 2019;234:17113-17126. [PMID: 30888066 DOI: 10.1002/jcp.28470] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
29 Song W, Miao DL, Chen L. Comprehensive analysis of long noncoding RNA-associated competing endogenous RNA network in cholangiocarcinoma. Biochem Biophys Res Commun 2018;506:1004-12. [PMID: 30404735 DOI: 10.1016/j.bbrc.2018.10.186] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
30 Yan B, Li H, Jiang W, Mu L. An Adeninate-Based Metal–Organic Framework for Antitumour Drug Delivery and Anti-Osteogenic Sarcoma Activity Evolution. Aust J Chem 2018;71:978. [DOI: 10.1071/ch18287] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]